about
Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosisDiagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemiaModulation of hepcidin to treat iron deregulation: potential clinical applications.HFE C282Y homozygotes are at increased risk of breast and colorectal cancerProfound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.Characteristics of the arthropathy described in hereditary hemochromatosis.Pathogenesis of liver cirrhosis.Endocrine dysfunction in hereditary hemochromatosis.Diagnosing and preventing iron overload.Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.Iron: an emerging factor in colorectal carcinogenesis.Hepatic iron loading in mice increases cholesterol biosynthesis.Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors.A comparison of self-reported and record-linked blood donation history in an Australian cohort.High resolution melting analysis to genotype the most common variants in the HFE gene.Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load
P2860
Q35090624-8FD0B261-5EB2-4991-8C56-2430D28FA019Q35144263-6893BD68-58B8-4F76-A978-6FBE3205DBCEQ36753262-26693450-1B9A-4936-AD1F-3D6EA9C5CAD1Q36847852-1203E72C-06BD-4D80-8C46-BE9152258383Q37274209-8E833AE2-28CE-4AF2-A7C7-0A991C2B27DDQ37458594-284A4406-D379-4715-B46A-E15F0934164EQ37876385-450F9D0A-354C-4BB5-95D9-5BC1B5928EFAQ38223369-A8D78878-C5FC-40E2-841C-78A116B6F7C1Q38763948-0AB60880-89CD-48F2-953A-8BC732A179C4Q39192941-9EFCE291-1BAB-4DF3-8DC5-BC6CBA8A1BF9Q42720829-293647C7-9AEB-432F-9441-5AFAB04FBC11Q42922519-AB1A5BB6-FE2A-4C2B-8CB2-7B58511EB539Q42947256-CC671859-B01D-49E4-B35E-96ECEB261937Q43184153-B198F0F5-708A-4044-8D75-184EC4E53975Q45399914-573E747F-724E-4174-8048-2C027039121CQ50519632-A1B508CC-7F95-4A2A-814E-68448AE633FBQ56898252-6BF2564A-08B4-41AC-A914-22D5380EC7E9
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Hereditary hemochromatosis in the post-HFE era
@ast
Hereditary hemochromatosis in the post-HFE era
@en
Hereditary hemochromatosis in the post-HFE era
@nl
type
label
Hereditary hemochromatosis in the post-HFE era
@ast
Hereditary hemochromatosis in the post-HFE era
@en
Hereditary hemochromatosis in the post-HFE era
@nl
prefLabel
Hereditary hemochromatosis in the post-HFE era
@ast
Hereditary hemochromatosis in the post-HFE era
@en
Hereditary hemochromatosis in the post-HFE era
@nl
P2093
P2860
P356
P1433
P1476
Hereditary hemochromatosis in the post-HFE era
@en
P2093
Bruce R Bacon
Debbie Trinder
Grant A Ramm
Robert S Britton
P2860
P304
P356
10.1002/HEP.22507
P407
P577
2008-09-01T00:00:00Z